SARWAT SIPRA: Open Payments
NPI 1407495849 · FRESNO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,031 in 28 payments from 12 companies in 2025. Trend: 2023 $1,012 · 2024 $848 · 2025 $1,031
Food & beverage: $1,013Education: $17
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 3 | $308 |
| Novo Nordisk Inc | 2 | $151 |
| Insmed, Inc. | 4 | $114 |
| Amgen Inc. | 5 | $97 |
| Lilly USA, LLC | 5 | $94 |
| AstraZeneca Pharmaceuticals LP | 1 | $92 |
| Regeneron Healthcare Solutions, Inc. | 3 | $84 |
| SHIELD THERAPEUTICS INC | 1 | $20 |
| Sage Therapeutics, LLC | 1 | $20 |
| SANOFI-AVENTIS U.S. LLC | 1 | $19 |
Products named: FREESTYLE LIBRE 3, Wegovy, Arikayce, MOUNJARO, TEZSPIRE, DUPIXENT, OTEZLA, ACCRUFER.
Industry payments across CA — which companies pay providers there.
